|
|||||
|
|||||
Hello Nature readers, |
|||||
![]() |
|||||
A reproducibility study focused on three of the most common biomedical research methods used in Brazil: an assay of cell metabolism, a technique for amplifying genetic material and a type of maze test for rodents. (Mauro Pimentel/AFP/Getty) | |||||
Reproducibility tests find dismaying resultsIn an unprecedented effort, a coalition of more than 50 research teams has double-checked a swathe of Brazilian biomedical studies — and was able to replicate less than half. That rate is in keeping with that found by other large-scale attempts to reproduce scientific findings. But the latest work assessed publications “based on methods, rather than research area, perceived importance or citation counts”, says metascience researcher Mariana Boechat de Abreu, one of the project coordinators. “We now have the material to start making changes from within” to improve the status quo, says de Abreu. Nature | 5 min readReference: bioRxiv preprint (not peer reviewed) |
|||||
Gut microbes might help ease fibromyalgiaResults of a small trial hint that microbes associated with a healthy gut microbiome could ease the symptoms of fibromyalgia — a debilitating and poorly-understood chronic pain condition. Fourteen women with the condition received an experimental therapy containing gut bacteria from healthy women. All but two reported an improvement in their symptoms such as pain, anxiety and sleep disturbances. The trial is so small that “we should take the results with a grain of salt”, says co-organizer and pain scientist Amir Minerbi. “But it is encouraging [enough] to move forward.” Nature | 5 min readReference: Neuron paper |
|||||
Question of the weekDo you use LinkedIn? We’re working on a guide for scientists to the work-focused social network, and we’d love to hear how you’ve found it useful. Has LinkedIn got you a job, found you a mentor or launched some other exciting professional connection? Let us know at briefing@nature.com. |
|||||
|
|||||
How it feels to glimpse a new colourBy selectively activating certain retinal cells with lasers, scientists made five people perceive a never-before-seen blue-greenish hue called ‘olo’. In The Atlantic, the researchers share how it felt to see a new colour. “As a scientist, the experience was profound,” says optics researcher Austin Roorda. “How many people have named a colour?” notes computer scientist James Fong, who had that honour. But Fong still hasn’t seen ‘olo’ — the first author wasn’t one of the winners when the team drew lots for who would participate in the experiment; something he hopes to soon rectify. “I would be disappointed if I finished my PhD program without seeing the colour that I spent a good fraction of my time here studying.” The Atlantic | 8 min readReference: Science Advances paper |
|||||
Facing a preventable HIV pandemic“There are patients you can never forget,” writes physician Chris Beyrer. So starts a harrowing recollection of treating an orphaned toddler, Baby M, as he died from AIDS in a US hospital in the 1980s. Beyrer says he is reliving that traumatic experience as he watches the dismantling of US foreign aid by the administration of US president Donald Trump, including an “unconscionable” pause on the AIDS-relief programme PEPFAR. “When I saw the modelling outcomes — that estimate of 135,000 preventable infant infections, Baby M’s face flashed across my mind’s eye,” writes Beyrer, who is a past president of the International AIDS Society. “We will resist going backward to those early years with all we have.” The Lancet | 8 min read (free reg required) |
|||||
Futures: Wild strawberries on MarsA farmer grows tired of obnoxious tourists in the latest short story for Nature’s Futures series. Nature | 6 min read |
|||||
Quote of the day“When we speak about climate change in the sea, we don’t need to think about somewhere in the Arctic or Antarctic. It’s happening here in Barcelona.”Marine biologist Joaquim Garrabou is one of the researchers pioneering Spanish climate solutions as the crisis hits home. (Nature | 10 min read, part of Nature Spotlight: Spain) |
|||||
|
|||||
|
|||||
|
|||||
Free newsletters from NatureWant more? Update your preferences to sign up to our other Nature Briefing newsletters:
|
|||||
Access Nature and 54 other Nature journals
Nature+ is our most affordable 30-day subscription, giving you online access to a wide range of specialist Nature Portfolio journals, including Nature. |
|||||
|
|||||
You received this newsletter because you subscribed with the email address: nporo0xxhr@niepodam.pl Please add briefing@nature.com to your address book. Enjoying this newsletter? You can use this form to recommend it to a friend or colleague — thank you! Had enough? To unsubscribe from this Briefing, but keep receiving your other Nature Briefing newsletters, please update your subscription preferences. To stop all Nature Briefing emails forever, click here to remove your personal data from our system. Fancy a bit of a read? View our privacy policy. Forwarded by a friend? Get the Briefing straight to your inbox: subscribe for free. Want to master time management, protect your mental health and brush up on your skills? Sign up for our free short e-mail series for working scientists, Back to the lab. Get more from Nature: Register for free on nature.com to sign up for other newsletters specific to your field and email alerts from Nature Portfolio journals. Would you like to read the Briefing in other languages? 关注Nature Portfolio官方微信订阅号,每周二为您推送Nature Briefing精选中文内容——自然每周简报。 Nature Portfolio | The Springer Nature Campus, 4 Crinan Street, London, N1 9XW, United Kingdom Nature Portfolio, part of Springer Nature. |